Early screening for post-stroke depression and its effect on functional outcomes, quality of life, and mortality: A meta-analysis

Table 1 Characteristics of included studies, mean ± SD

Ref.	Year	Country	Sample size	Age	Gender (Male %)	Screening tool	Outcome measures
Thomas et al[9]	2019	United Kingdom	48	68.45 ± 3.51	52.7	PHQ-9	FIM, SS-QoL, mortality
Almeida et al[10]	2021	Australia	607	70.12 ± 2.83	49.3	HADS	FIM, SS-QoL, mortality
Gao et al[12]	2017	China	274	69.33 ± 3.24	47.5	CES-D	FIM, SS-QoL, mortality
Hackett et al[13]	2010	Australia	200	71.29 ± 2.65	55.4	PHQ-9	FIM, SS-QoL, mortality
Almeida et al[11]	2022	Australia	1221	67.84 ± 3.10	50.6	HADS	FIM, SS-QoL, mortality
Trompetto et al[14]	2013	Italy	110	72.40 ± 3.79	53.1	GDS	FIM, SS-QoL, mortality

FIM: Functional independence measure; SS-QoL: Stroke-Specific Quality of Life Scale.